Phase 3 Lung Cancer Trial, Not Yet Recruiting NCT05496166 Sponsor: Shanghai Pulmonary Hospital, Shanghai, China Condition: Lung Cancer
Back to Lung Cancer

Phase 3 Lung Cancer Trial, Not Yet Recruiting

NCT05496166
Not Yet Recruiting Phase 3

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have given their signed informed consent to participate.
  • People aged 18 to 70 years old.
  • People who have been confirmed through tissue or cell testing to have small cell lung cancer (SCLC) that is at a limited stage and have not yet received any treatment for it.
  • People with clinical stage IIB–III disease who have had a procedure called EBUS (a type of internal camera examination) to check lymph nodes and rule out hidden spread to those nodes.
  • People whose cancer has been assessed by two chest surgeons as likely to be removable by surgery after 4 cycles of treatment (confirm with trial site).
  • People with a physical fitness score of 0 or 1 on a standard medical scale (meaning generally active and able to carry out daily activities with little or no restriction).
  • People expected to live for at least 12 weeks.
  • People who have at least one measurable tumour that can be tracked during the trial.
  • People whose liver, kidneys, and blood system are functioning within acceptable ranges, based on blood test results — including healthy enough levels of white blood cells, platelets, haemoglobin, clotting factors, and liver-related markers (specific thresholds apply; confirm with trial site).
  • Women who could become pregnant must agree to use highly effective contraception throughout the study and for at least 120 days after the last dose of treatment, and must have a negative pregnancy test within 7 days before starting.
  • Men who have not been surgically sterilised must agree to use highly effective contraception throughout the study and for at least 120 days after the last dose of treatment.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have previously received any cancer treatment, including surgery, radiotherapy, chemotherapy, targeted therapy, or experimental treatment.
  • People who have had another type of cancer at any point in the five years before the trial starts.
  • People with unstable ongoing health conditions, such as uncontrolled high blood pressure or serious irregular heartbeat.
  • People who have an active autoimmune disease, or a nerve or muscle condition related to their cancer that requires treatment affecting the whole body.
  • People who are allergic to the study drug.
  • People who have had or currently have a lung condition called interstitial lung disease.
  • People who have HIV or active hepatitis.
  • People who have had major surgery or a serious physical injury within the 2 months before the trial begins.
  • Women who are pregnant or breastfeeding.
  • People who have a neurological condition or mental illness that would prevent them from cooperating with the study.
  • People whom the trial investigators consider unsuitable for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 3
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Registry
ClinicalTrials.gov
Start date
1 August 2023
Est. completion
1 August 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

progression-free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov